Creative Biosciences has collected $88m in fresh funding, five years after being founded by a Sun Yat-Sen University professor.

Novo and Bristol Myers-Squibb formed part of a group of new and existing backers that provided cash to Galecto, based on research from the universities of Lund and Edinburgh.

A group of new and existing backers have provided cash to Galecto, based on research from the universities of Lund and Edinburgh.

Kinnevik has led the LeFrak-backed community housing service provider’s latest round, taking its overall funding in excess of $110m.

Twitter has returned to back the social media platform that provides services in 15 Indian languages, which pushed its total funding to about $264m.

Eight Roads Ventures returned for the First Data-backed payment software developer’s series D round, announced alongside two strategic acquisitions.

Cancer drug developer Silverback has secured $211m to date from investors including BMS, Celgene and Alexandria Real Estate Equities.

Lenovo Capital has chipped into the RPA software provider’s latest funding, which will go toward improving its products and entering new markets.

Existing investors Johnson & Johnson and WuXi AppTec have returned to take part in the neurological drug developer’s latest funding.

Willow, which markets discreet breastfeeding pump technology, reportedly counts Johnson & Johnson Innovation – JJDC as an investor.